Discover open access scientific publications

Search, annotate, share and cite publications

Publications by XiaoYan Ma

Niraparib Activates Interferon Signaling and Potentiates Anti-Pd-1 Antibody Efficacy in Tumor Models

Scientific Reports

Multidisciplinary

2019

English

Analysis of Rural Landscape Pattern Based on GIS in Yanqing, Beijing

2016

English

Related publications

PD-L1 Checkpoint Blockade Delivered by Retroviral Replicating Vector Confers Anti-Tumor Efficacy in Murine Tumor Models

Oncotarget

Oncology

2019

English

Prognostic Significance of Pd-L1 and Phosphorylated Erk Expression in T-Cell Lymphoma: Pd-1/Pd-L1 Axis Activates Intracellular Erk Signaling in Tumor Cells

Hematological Oncology

English

Robust Antitumor Effects of Combined Anti-Cd4-Depleting Antibody and Anti-Pd-1/Pd-L1 Immune Checkpoint Antibody Treatment in Mice

Cancer immunology research

Cancer Research

Immunology

2015

English

Poor Outcome With Anti-Programmed Death-Ligand 1 (PD-L1) Antibody Due to Poor Pharmacokinetic Properties in PD-1/PD-L1 Blockade-Sensitive Mouse Models

Journal for ImmunoTherapy of Cancer

English

Safety and Tumor Responses With Lambrolizumab (Anti–PD-1) in Melanoma

New England Journal of Medicine

Medicine

2013

English

Anti-Tumor Efficacy and Biomarker Evaluation of Agonistic Anti-Ox40 Antibodies in Preclinical Models

Journal for ImmunoTherapy of Cancer

English

Rationale of Combination of Anti-Pd-1/Pd-L1 Antibody Therapy and Radiotherapy for Cancer Treatment

International Journal of Clinical Oncology

English

Comment on ‘Efficacy and Toxicity of Treatment With the Anti-Ctla-4 Antibody Ipilimumab in Patients With Metastatic Melanoma After Prior Anti-Pd-1 Therapy’

British Journal of Cancer

Cancer Research

Oncology

2017

English

Myeloid Maturation Potentiates STAT3-mediated Atypical IFN-γ Signaling and Upregulation of PD-1 Ligands in AML and MDS

Scientific Reports

Multidisciplinary

2019

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by XiaoYan Ma

Niraparib Activates Interferon Signaling and Potentiates Anti-Pd-1 Antibody Efficacy in Tumor Models

Analysis of Rural Landscape Pattern Based on GIS in Yanqing, Beijing

Related publications

PD-L1 Checkpoint Blockade Delivered by Retroviral Replicating Vector Confers Anti-Tumor Efficacy in Murine Tumor Models

Prognostic Significance of Pd-L1 and Phosphorylated Erk Expression in T-Cell Lymphoma: Pd-1/Pd-L1 Axis Activates Intracellular Erk Signaling in Tumor Cells

Robust Antitumor Effects of Combined Anti-Cd4-Depleting Antibody and Anti-Pd-1/Pd-L1 Immune Checkpoint Antibody Treatment in Mice

Poor Outcome With Anti-Programmed Death-Ligand 1 (PD-L1) Antibody Due to Poor Pharmacokinetic Properties in PD-1/PD-L1 Blockade-Sensitive Mouse Models

Safety and Tumor Responses With Lambrolizumab (Anti–PD-1) in Melanoma

Anti-Tumor Efficacy and Biomarker Evaluation of Agonistic Anti-Ox40 Antibodies in Preclinical Models

Rationale of Combination of Anti-Pd-1/Pd-L1 Antibody Therapy and Radiotherapy for Cancer Treatment

Comment on ‘Efficacy and Toxicity of Treatment With the Anti-Ctla-4 Antibody Ipilimumab in Patients With Metastatic Melanoma After Prior Anti-Pd-1 Therapy’

Myeloid Maturation Potentiates STAT3-mediated Atypical IFN-γ Signaling and Upregulation of PD-1 Ligands in AML and MDS